Mirxes Holding Company Limited said it won the bid on March 3, 2026 for the 2026 Lianxi District Gastric Cancer Screening and Early Intervention Project, its first public health early cancer screening programme and first government procurement project in China. The project budget is RMB8.100 million, with a maximum bid price of RMB7.695 million, and is expected to provide early gastric cancer screening services for about 30,000 residents in Lianxi District, Jiujiang, Jiangxi, representing about 8% of the district’s approximately 418,000 population. Mirxes said the programme will use its GASTROClear blood-based gastric cancer screening product, which has obtained a Class III Medical Device Registration Certificate from China’s National Medical Products Administration.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mirxes Holding Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260305-12041855), on March 05, 2026, and is solely responsible for the information contained therein.